Community/Retail

Medical schools are working to bring AR and VR technology into the classroom. Could pharmacy do the same?

Obesity has been considered a risk factor for severe acute respiratory illness, including more severe cases of the flu, but a recently-published study found that weight may not be associated with increased illness severity.

Pharmacists are exposed to increasing job stress. Why does that matter?

March is National Sleep Awareness Month, and pharmacists can help patients get their rest.

Many small health start-ups are leveraging digital health and telemedicine services to provide patient coaching. A new study from one company demonstrates that users could see as much as a 0.8% reduction in A1c.

The American College of Physicians (ACP) recently issued new guidelines aimed at assisting clinicians in making decisions about targets when using pharmacologic therapy in adults with type 2 diabetes.

Officials with the FDA have approved a supplemental new drug application (sNDA) to expand the use of lurasidone HCl (Latuda, Sunovion) to include the treatment of bipolar depression in pediatric patients (10 to 17 years of age).

The online retailing giant has its own brand of nonprescription drugs. Can it compete?

Talk to your patients about alternative therapy with these tips

The past decade has seen a large change in the field of pharmacy, with many companies changing the landscape with new mergers and acquisitions.

Looking to get their data into clinician hands, Higi has teamed up with Rush to get their data into institutions using Epic's EHRs.

More smart inhalers are coming to the US market and pharmacists may see them soon.

Officials with the FDA have approved ibalizumab-uiyk (Trogarzo, TaiMed Biologics), the first antiretroviral medication for adults with HIV who cannot be successfully treated with other therapies.

Getting to your medical appointment can be a pain, so why not call on Uber or Lyft? Well, soon you'll get your chance.

A new direct-to-consumer test analyzes saliva for 3 BRCA variants that may elevate the risk of various types of cancer.

The IDSA and SHEA have made a recent update to the previously published practice guidelines for CDI. While many of the recommendations remain the same, there are a few key changes that the update has addressed.

Personalized inpatient assessments prior to prescribing asthma therapy to pediatric patients can improve the accuracy and quality of care.

Are you a busy professional? Think eating healthy is difficult? It doesn't have to be!

Opioid allergies are often misdiagnosed. Improper allergy diagnosis may lead to delays in treatment and unnecessary drug avoidance.

Patients with cell phones at the pharmacy is a growing issue.

An international team of respiratory disease specialists looked back at 2017 and assembled a review of the current approaches to asthma and chronic obstructive pulmonary disease.

Technology is great when it works, but in this case, the issue of recieving the wrong amount of insulin can be problematic.

Sanofi recently announced that the FDA has accepted the supplemental Biologics License Application (sBLA) of dupilumab (Dupixent) for the maintenance treatment of asthma.

Pharmacy conferences provide great opportunities to expand your professional horizons.

With new smartphones able to measure blood pressure, what does this mean for other companies who solely make these devices?

Can home voice assistants be the future of medication management in the near future?

WHO officials noted that “recent A(H3N2) viruses were better inhibited by ferret antisera raised against the egg-propagated reference virus A/Singapore/INFIMH-16-0019/2016 compared to ferret antisera raised against other recent egg-propagated A(H3N2) viruses.”

Despite signs that influenza activity is declining, overall activity remains elevated across most of the United States following this season’s peak in early February.

Officials with the FDA have issued a statement warning Consumers to be wary of unapproved products that claim to prevent, treat, or cure influenza.

We all make important interventions as pharmacists, but we don’t make front page headlines.